Literature DB >> 9231935

Late-onset Huntington's disease: a clinical and molecular study.

C M James1, G D Houlihan, R G Snell, J P Cheadle, P S Harper.   

Abstract

Using the Huntington's disease register for South Wales, a total of 86 affected individuals were identified living in the counties of Mid Glamorgan, South Glamorgan and Gwent, giving a point prevalence rate for Huntington's Disease in South East Wales of 6.2/100,000. Only four (4.7%) of these individuals developed their symptoms after the age of 60 years. A subsequent retrospective search of the register identified a total of 33 individuals with clinical evidence of Huntington's disease and whose age of onset of symptoms occurred between the ages of 60 and 77 years. In this group the median time for disease duration from the onset of symptoms was 13 years (range 0.5-25 years), with survival up to age 86 years recorded. Initial symptoms of Huntington's disease included disturbance of gait in 32 individuals; 31 had involuntary movements, and 20 had abnormality of speech. Major psychiatric symptoms were present in only six cases; but approximately a third (ten cases) had symptoms related to impaired cognitive function. Molecular analysis was possible on ten individuals in the series. The expanded CAG repeat sequence in the Huntington's disease gene was found in all cases, with a narrow range of 36-38 repeats, representing the smallest repeats seen in our Huntington's disease group. Our study suggests that Huntington's disease in elderly people causes predominantly motor disturbance at onset with relatively mild disability and a favourable outlook for both independent living and for life expectancy. However, the potential for under-diagnosis in this age group may have considerable genetic consequences, with transmission of the disorder to numerous descendants by the time its hereditary nature is recognized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9231935     DOI: 10.1093/ageing/23.6.445

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  13 in total

1.  Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.

Authors:  M A Ramos-Arroyo; S Moreno; A Valiente
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

2.  Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.

Authors:  Jussi O T Sipilä; Tommi Kauko; Markku Päivärinta; Kari Majamaa
Journal:  J Neurol       Date:  2017-08-28       Impact factor: 4.849

3.  Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.

Authors:  P Kehoe; M Krawczak; P S Harper; M J Owen; A L Jones
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

4.  Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases.

Authors:  D Falush; E W Almqvist; R R Brinkmann; Y Iwasa; M R Hayden
Journal:  Am J Hum Genet       Date:  2001-02       Impact factor: 11.025

Review 5.  A systematic review of the incidence and prevalence of long-term neurological conditions in the UK.

Authors:  Thomas Hoppitt; Hardev Pall; Mel Calvert; Paramjit Gill; Guiqing Yao; Jill Ramsay; Gill James; Jacky Conduit; Cath Sackley
Journal:  Neuroepidemiology       Date:  2010-11-17       Impact factor: 3.282

6.  Porous Carbon Boosted Non-Enzymatic Glutamate Detection with Ultra-High Sensitivity in Broad Range Using Cu Ions.

Authors:  Yifei Ma; Jiemin Han; Zhaomin Tong; Jieling Qin; Mei Wang; Jonghwan Suhr; Jaedo Nam; Liantuan Xiao; Suotang Jia; Xuyuan Chen
Journal:  Nanomaterials (Basel)       Date:  2022-06-09       Impact factor: 5.719

7.  Huntington disease reduced penetrance alleles occur at high frequency in the general population.

Authors:  Chris Kay; Jennifer A Collins; Zosia Miedzybrodzka; Steven J Madore; Erynn S Gordon; Norman Gerry; Mark Davidson; Ramy A Slama; Michael R Hayden
Journal:  Neurology       Date:  2016-06-22       Impact factor: 9.910

8.  Late onset Huntington Disease: clinical and genetic characteristics of 34 cases.

Authors:  Hillary Lipe; Thomas Bird
Journal:  J Neurol Sci       Date:  2008-10-31       Impact factor: 3.181

9.  Oromandibular dyskinesia as the initial manifestation of late-onset huntington disease.

Authors:  Dong-Seok Oh; Eun-Seon Park; Seong-Min Choi; Byeong-Chae Kim; Myeong-Kyu Kim; Ki-Hyun Cho
Journal:  J Mov Disord       Date:  2011-10-30

Review 10.  What do we know about Late Onset Huntington's Disease?

Authors:  Sai S Chaganti; Elizabeth A McCusker; Clement T Loy
Journal:  J Huntingtons Dis       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.